Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab by Hanley TL, Yiu ZZN

Get full text

Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management [Corrigendum] by Al-Janabi A, Yiu ZZN

Get full text

Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management by Al-Janabi A, Yiu ZZN

Get full text

Assessment and monitoring of biologic drug adverse events in patients with psoriasis by Hanley T, Handford M, Lavery D, Yiu ZZN

Get full text

Quantitative evaluation of biologic therapy options for psoriasis: a systematic review and network meta-analysis – correction by Smith, CH, Mahil, SK, Yiu, ZZN, Bale, T, Burden, AD, Coates, LC, McGuire, A, Murphy, R, Owen, CM, Parslew, R, Uthman, OA, Woolf, RT, Manounah, L, Ezejimofor, MC, Exton, LS, Mustapa, FMM

Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis by Mahil, SK, Ezejimofor, MC, Exton, LS, Manounah, L, Burden, AD, Coates, LC, de Brito, M, McGuire, A, Murphy, R, Owen, CM, Parslew, R, Woolf, RT, Yiu, ZZN, Uthman, OA, Mohd Mustapa, MF, Smith, CH

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023 - a pragmatic update. by Smith, CH, Yiu, ZZN, Bale, T, Burden, AD, Coates, LC, Eckert, E, Longley, N, Mahil, SK, McGuire, A, Murphy, R, Nelson-Piercy, C, Owen, CM, Parslew, R, Woolf, RT, Mansour Kiaee, Z, Constantin, AM, Ezejimofor, MC, Exton, LS, Mohd Mustapa, MF